| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Current Issue > Current Issue



Table of Contents | September, 2019  Vol. 25  No.3 Previous Issue | Next Issue | Archive
In this issue:




Reviews
223 Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol.2019;25(3):223-233.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0107
                                 Cited By 1
234 Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Seong Kyun Na, Byung-Cheol Song
Clin Mol Hepatol.2019;25(3):234-244.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0108
                                 Cited By 1
245 Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee
Clin Mol Hepatol.2019;25(3):245-263.   Published online February 14, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0090
                                 Cited By 2
264 Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol.2019;25(3):264-269.   Published online March 4, 2019     
DOI: https://doi.org/10.3350/cmh.2019.1001
                                 Cited By 2
270 Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Ankur Jindal, Rakesh Kumar Jagdish
Clin Mol Hepatol.2019;25(3):270-279.   Published online April 22, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0015
                                 Cited By 1
Editorial
280 How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Jung Hwan Yu, Jin-Woo Lee
Clin Mol Hepatol.2019;25(3):280-282.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0104
                              
Original Articles
283 Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol.2019;25(3):283-293.   Published online November 13, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0054
                              Supplementary         Cited By 1
294 Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee
Clin Mol Hepatol.2019;25(3):294-304.   Published online May 30, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0086
                              
305 Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol.2019;25(3):305-316.   Published online April 19, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0004
                              
317 Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
Elham Ahmed Hassan, Abeer Sharaf El-Din Abdel Rehim, Mohamed Omar Abdel-Malek, Asmaa Omar Ahmed, Nourhan Mahmoud Abbas
Clin Mol Hepatol.2019;25(3):317-325.   Published online June 10, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0097
                              
Letters to the editor
326 Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
Rahul Kumar, John Chen Hsiang, Jessica Tan, Prem Harichander Thurairajah
Clin Mol Hepatol.2019;25(3):326-330.   Published online December 4, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0063
                              
331 Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas
Clin Mol Hepatol.2019;25(3):331-332.   Published online May 30, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0034
                              
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 156
TOTAL : 268620